CHIR-11509

N/A

Report date: 2024/12/03 16:45:12

Base Information

Drug NameCHIR-11509
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUrokinase plasminogen activator inhibitors
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsArthritis, RheumatoidNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChiron Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChiron Corp
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A